Compare FLNT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNT | CVRX |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1M | 81.3M |
| IPO Year | 2009 | 2021 |
| Metric | FLNT | CVRX |
|---|---|---|
| Price | $3.03 | $2.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.50 | ★ $10.50 |
| AVG Volume (30 Days) | 32.3K | ★ 827.6K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,764,000.00 | $56,651,000.00 |
| Revenue This Year | $5.89 | $17.17 |
| Revenue Next Year | $12.62 | $17.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $1.70 | $2.20 |
| 52 Week High | $4.49 | $11.30 |
| Indicator | FLNT | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.66 | 36.99 |
| Support Level | $2.95 | $2.20 |
| Resistance Level | $3.05 | $3.33 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 8.52 | 15.97 |
Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.